Dr Kalyanam Shivkumar Named New Editor of JACC: Clinical Electrophysiology

A specialist in interventional cardiac electrophysiology, Dr Kalyanam Shivkumar has developed several innovative techniques for the catheter ablation of cardiac arrhythmias and other cardiac interventions. His research work, both basic/translational and clinical, relates to mechanisms of cardiac arrhythmias in humans and the role of the autonomic nervous system in sudden cardiac death.

Shivkumar has been elected as a Fellow of the American College of Cardiology (FACC) and to the membership of the American Society of Clinical Investigation.

“It is a rare honor and a privilege to serve as the editor-in-chief of JACC: Clinical Electrophysiology,” Shivkumar said. “Our editorial team looks forward to seeking and publishing the very best science in the field of cardiac arrhythmias.”

Launched in 2015, JACC: Clinical Electrophysiology is a monthly subspecialty journal encompassing all aspects of the epidemiology, pathogenesis, diagnosis and treatment of cardiac arrhythmias. The journal occupies a unique position by focusing primarily on the practicing clinical electrophysiologist’s need for context and critical information to direct therapeutic decision making. It aims to publish only the highest caliber papers and authors, focusing on content that advances the field.

Shivkumar’s first issue of JACC: Clinical Electrophysiology will publish in July 2020.


Other non-profit news.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version